ARRDC3 and esophageal squamous cell carcinoma: The above results indicated that miR-624 could target ARRDC3 and inhibit its expression in ESCC cells, and thereby weaken the degradation of YAP caused by the co-precipitation of ARRDC3 and YAP, thus promoting the expression of YAP.